Voltron Therapeutics, a Lucius Partners Company, with the VIC at MGH Announces $5.88 Million Award from U.S. DoD
Award will advance the Self-Assembling Vaccine Platform for rapid production of vaccines with Massachusetts General Hospital’s Vaccine and Immunotherapy Center NEW YORK, NY, UNITED STATES, August 17, 2023/EINPresswire.com/ -- Voltron Therapeutics, Inc., a Lucius Partners Portfolio [...]
Lucius Partners Portfolio Company Voltron Therapeutics, Inc Adds Manufacturing Expert to Scientific Advisory Board
Globally recognized manufacturing and product supply expert Tibor Nemes joins Scientific Advisory Board NEW YORK, NY, UNITED STATES, September 14, 2023/EINPresswire.com/ -- Voltron Therapeutics, Inc., a Lucius Partners portfolio company, today announced that Tibor Nemes, [...]
Lucius Partners Portfolio Company Voltron Therapeutics Announces Robust Immunogenicity Data: Key Prostate Cancer Target
Self Assembling Vaccine targets Prostate Stem Cell Antigen Vaccine induces immunity against an immunogenic protein; expands platform’s potential targets NEW YORK, NEW YORK, UNITED STATES, September 6, 2023/EINPresswire.com/ -- Voltron Therapeutics, Inc., a Lucius [...]
Voltron Therapeutics, a Lucius Partners Company, with the VIC at MGH Announces $5.88 Million Award from U.S. DoD
Voltron Therapeutics, a Lucius Partners Company, with the VIC at MGH Announces $5.88 Million Award from U.S. DoD Award will advance the Self-Assembling Vaccine Platform for rapid production of vaccines with Massachusetts General Hospital’s Vaccine and Immunotherapy [...]
Lucius Partners Portfolio Company Voltron Therapeutics, Inc. Announces Sponsored Research Agreement with the Massachusetts General Hospital, Harvard Medical School, to Initiate a Pre-clinical Immuno-Oncology Trial
Lucius Partners Portfolio Company Voltron Therapeutics, Inc. Announces Sponsored Research Agreement with the Massachusetts General Hospital, Harvard Medical School, to Initiate a Pre-clinical Immuno-Oncology Trial Self Assembling Vaccine will target Prostate Stem Cell Antigen [...]
Voltron Therapeutics, Inc., a Lucius Partners Portfolio Company, Announces Poster Presentation at the Military Health System Research Symposium
Voltron Therapeutics, Inc., a Lucius Partners Portfolio Company, Announces Poster Presentation at the Military Health System Research Symposium Poster demonstrates the utility of Voltron’s Self-Assembling Vaccine platform in Pandemic Preparedness and Immuno-Oncology [...]